|
Status |
Public on Nov 02, 2007 |
Title |
Melanoma (AF500KNSPSKMEL2) |
Sample type |
genomic |
|
|
Source name |
SKMEL2 Cell Line
|
Organism |
Homo sapiens |
Characteristics |
Melanoma
|
Growth protocol |
Cells were grown in in RPMI 1640 supplemented with 10% heat-inactivated FBS
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was isolated from cultured cells with Mini DNeasy kit (Qiagen, Inc.)
|
Label |
biotin
|
Label protocol |
250 ng Genomic DNA was biotinylated as described by manufacturer (Genechip Mapping 500k assay manual 701930 Rev.3 or 100k assay manual 701684 Rev.3, Affymetrix).
|
|
|
Hybridization protocol |
Hybridizations were performed according to the standard manufacturer's describe in Genechip Mapping 500k assay manual 701930 Rev.3 or 100k assay manual 701684 Rev.3, Affymetrix.
|
Scan protocol |
Scanning was done using an Affymetrix 3000 microarray scanner. Specifications can be found in Genechip Mapping 500k assay manual 701930 Rev.3 or 100k assay manual 701684 Rev.3, Affymetrix
|
Description |
Melanoma
|
Data processing |
Image files were analyzed using the dChip software. A panel of chips (n = 12) assayed with germline DNA served as a reference in order to calculate a test/reference ratio. The ratios were then subject global normalization that assumed that the median copy number is diploid (2n; log2 Ratio = 0).
|
|
|
Submission date |
May 09, 2007 |
Last update date |
Oct 31, 2007 |
Contact name |
Joel Greshock |
Organization name |
GlaxoSmithKline
|
Department |
Translational Medicine, Oncology
|
Street address |
2301 Renaissance Blvd.
|
City |
King of Prussia |
State/province |
PA |
ZIP/Postal code |
19406 |
Country |
USA |
|
|
Platform ID |
GPL3718 |
Series (1) |
GSE7822 |
A comparison of DNA copy number profiling platforms using a panel of melanoma cell lines |
|